Page last updated: 2024-11-07

metaraminol and Malaria

metaraminol has been researched along with Malaria in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DAVIS, JW1

Other Studies

1 other study available for metaraminol and Malaria

ArticleYear
VASOPRESSOR INDUCED MALARIAL RELAPSE AS A COMPLICATION OF ACUTE MYOCARDIAL INFARCTION: REPORT OF A CASE.
    Angiology, 1964, Volume: 15

    Topics: Cardiovascular Diseases; Drug Therapy; Malaria; Metaraminol; Myocardial Infarction; Recurrence; Shoc

1964
chemdatabank.com